Clinical Trials on Nausea With Vomiting Chemotherapy-Induced

Total 1699 results

Helsinn Healthcare SA

Active, not recruiting

Oral Akynzeo® vs Standard of Care in Preventing CINV in High-risk MEC Patients (MyRisk) (CINV)

Chemotherapy-induced Nausea and Vomiting

Spain, Germany, Switzerland, China, Czechia, United Kingdom, Greece
CR-CSSS Champlain-Charles-Le Moyne

Completed

Feasibility of Olanzapine at REduced doSe in hIGHly Emetogenic chemoTherapy (FORESIGHT)

Chemotherapy-induced Nausea and Vomiting

Canada
GlaxoSmithKline

Completed

A Study in Healthy Subjects to Assess How Dosing of Rifampin Affects What the Body Does to a Dose of GW679769 (Casopitant).

Nausea and Vomiting, Chemotherapy-Induced

United States
GlaxoSmithKline

Completed

The Effects Of GW679769 (Casopitant) On The Pharmacokinetics Of Docetaxel In Subjects With Cancer

Nausea and Vomiting, Chemotherapy-Induced

United States
Tesaro, Inc.

Completed

A Phase 1, 2-Part, Single Ascending Dose Assessment of the Safety, Tolerability, and Pharmacokinetics of Rolapitant Intravenous in Healthy Volunteers

Chemotherapy-induced Nausea and Vomiting

United States
The Hospital for Sick Children

Completed

Relative Bioavailability of an Extemporaneous Oral Suspension of Aprepitant in Healthy Adult Volunteers

Chemotherapy-induced Nausea and Vomiting

Canada
Merck Sharp & Dohme LLC

Terminated

A Study of MK-0869 (Aprepitant) and MK-0517 (Fosaprepitant) in Pediatric Participants Receiving Chemotherapy (MK-0869-134)

Chemotherapy-Induced Nausea and Vomiting
GlaxoSmithKline

Completed

To Investigate the Effect of Intravenous Ondansetron on Cardiac Conduction as Compared to Placebo and Moxifloxacin in Healthy Adult Subjects

Nausea and Vomiting, Chemotherapy-Induced

United States
GlaxoSmithKline

Completed

Study Of Healthy Subjects To Assess The Effect Of Ketoconazole And The Way The Body Will React To Casopitant [GW679769]

Nausea and Vomiting, Chemotherapy-Induced

United States
GlaxoSmithKline

Completed

The Pharmacokinetic Interaction Between Oral Casopitant and Oral Dolasetron, Granisetron or Rosiglitazone in Subjects

Nausea and Vomiting, Chemotherapy-Induced

United States
GlaxoSmithKline

Completed

A Study to Assess the Safety and Interaction Between Casopitant and Ketoconazole When Taken By Healthy Adults

Nausea and Vomiting, Chemotherapy-Induced

United States
Tesaro, Inc.

Completed

An Open Label, Single Dose, Three Part Study to Assess the Effects of Rolapitant (2 mg/mL IV Solution) on the Pharmacokinetics of Digoxin; Sulfasalazine; and the Cooperstown Cocktail (Midazolam, Omeprazole, Warfarin, Caffeine, and Dextromethorphan in Healthy Subjects

Chemotherapy-induced Nausea and Vomiting

United States
Merck Sharp & Dohme LLC

Completed

A Study to Assess the Bioequivalence of Aprepitant and Fosaprepitant and the Effect of Food on Aprepitant Bioavailability (0869-165)

Chemotherapy-Induced Nausea and Vomiting
All India Institute of Medical Sciences, New Delhi
Dr. Reddy's Laboratories Limited

Completed

Study to Evaluate Anti-emetic Effect of Aprepitant Versus Placebo in Children and Adolescent Receiving Chemotherapy (Aprepitant)

Chemotherapy Induced Nausea and Vomiting

India
Yung Shin Pharm. Ind. Co., Ltd.

Completed

Evaluate Bioequivalence of Palonosetron (0.25mg/5mL)

Chemotherapy-induced Nausea and Vomiting, Prophylaxis

Taiwan
Merck Sharp & Dohme LLC

Completed

Aprepitant and Fosaprepitant Time-on-Target PET (Positron Emission Tomography) Study (0869-183)

Chemotherapy-Induced Nausea and Vomiting (CINV)
Indiana University
Indiana University Health

Completed

Use of Aromatherapy to Reduce Symptom Burden

Chemotherapy-induced Nausea and Vomiting | Anxiety

United States
University of Aarhus
Danish Cancer Society; TrygFonden, Denmark; Børnecancerfonden; Ronald McDonalds...

Unknown

Designed Music Narratives for the Reduction of Side Effects of Chemotherapy in Children (7-12 Years) With Cancer

Cancer | Chemotherapy-induced Nausea and Vomiting | Effects of Chemotherapy

Denmark
Heron Therapeutics

Active, not recruiting

Safety Study of Repeat Doses of SUSTOL in Adults

Chemotherapy-Induced Nausea and Vomiting (CINV)

United States
Istanbul University - Cerrahpasa (IUC)
Koc University Hospital

Completed

The Effect of Breathing Exercise on Chemotherapy-induced Nausea and Vomiting in With Autologous Hematopoietic Stem Cell Transplantation Patients

Chemotherapy-induced Nausea and Vomiting

Turkey
M.D. Anderson Cancer Center
National Cancer Institute (NCI); Solvay Pharmaceuticals

Completed

Palonosetron and Dexamethasone With or Without Dronabinol in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy For Cancer

Chemotherapy-induced Nausea and Vomiting | Unspecified Adult Solid Tumor, Protocol Specific

United States
Shereen Mamdouh

Unknown

Effect of tDCS of the Motor Cortex on Chemotherapy Induced Nausia and Vomiting

Chemotherapy-induced Nausea and Vomiting

Egypt
Consorzio Oncotech

Completed

NEPA to Prevent Chemotherapy Induced Nausea and Vomiting in Patients With Breast Cancer (GIM15-NEPA)

Chemotherapy-induced Nausea and Vomiting
LG Life Sciences

Unknown

Phase 4 Trial to Evaluate the Efficacy and Safety of Sancuso Patch in CINV (Chemotherapy-induced Nausea and Vomiting) Associated With the Administration of MEC (Moderately Emetogenic Chemotherapy)

Chemotherapy-induced Acute or Delayed Nausea and Vomiting (CINV)

Korea, Republic of
Henan Cancer Hospital

Completed

Fosaprepitant , Tropisetron and Olanzapine for the Prevention of Nausea and Vomiting in Patients With Breast Cancer

Chemotherapy-induced Nausea and Vomiting

China
Helsinn Healthcare SA
The Physicians' Services Incorporated Foundation; George Clinical Pty Ltd

Completed

A Study to Assess the Safety and the Efficacy of IV Fosnetupitant/Palonosetron (260 mg/0.25 mg) Combination Compared to Oral Netupitant/Palonosetron (300 mg/0.5 mg) Combination for the Prevention of CINV in AC Chemotherapy in Women With Breast Cancer

Chemotherapy-induced Nausea and Vomiting

United States, Georgia
LG Life Sciences

Completed

Phase 4 Trial to Evaluate the Efficacy and Safety of Sancuso Patch in Chemotherapy-induced Nausea and Vomiting Associated With the Administration of Highly Emetogenic Chemotherapy (HEC)

Chemotherapy-induced Acute or Delayed Nausea and Vomiting (CINV)

Korea, Republic of
Kyowa Kirin Pharmaceutical Development Ltd

Completed

Safety and Pharmacokinetics of Sancuso and IV Granisetron in Patients Aged 13 to 17 Years

Chemotherapy Induced Nausea and Vomiting

United States
Kyowa Kirin Pharmaceutical Development Ltd

Withdrawn

Safety and Pharmacokinetics of Sancuso and IV Granisetron in Patients Aged 2 to 5 Years

Chemotherapy Induced Nausea and Vomiting
Kyowa Kirin Pharmaceutical Development Ltd

Withdrawn

Pharmacokinetics and Safety of Sancuso and IV Granisetron in Pediatrics Aged 6 to 12 Years

Chemotherapy Induced Nausea and Vomiting
GlaxoSmithKline

Withdrawn

A Study of IV Casopitant for the Prevention of Nausea and Vomiting Caused By Cisplatin-Based Highly Emetogenic Chemotherapy

Cancer | Solid Tumor Cancer | Chemotherapy-Induced Nausea and Vomiting | Nausea and Vomiting

United States, Canada
Lei Li

Unknown

Adherence to the Antiemesis National Comprehensive Cancer Network (NCCN) Guideline

Gynecologic Cancer | Chemotherapy-induced Nausea and Vomiting

China
Consorzio Oncotech

Unknown

Dexamethasone-sparing Approach Including NEPA Against Emesis Caused by Cisplatin (LUNG-NEPA)

Chemotherapy-induced Nausea and Vomiting

Italy
Fujian Shengdi Pharmaceutical Co., Ltd.

Completed

Study of HR20013 for Injection in Patients With Malignant Solid Tumors

Prevention of Nausea and Vomiting Caused by Highly Emetogenic Chemotherapy

China
Tianjin University of Traditional Chinese Medicine
National Basic Research Program, China

Completed

The Different Effectiveness of Single Acupoint（PC6 or CV12) vs Matching Acupoints(PC6 and CV12) in Chemotherapy-induced Nausea and Vomiting

to Evaluate the Effectiveness of Acupucnture in the Management of Chemotherapy-induced Nausea and Vomiting

China
Wuhan Union Hospital, China

Unknown

Aprepitant for the Prevention of Chemotherapy-induced Nausea and Vomiting (CINV)

Chemotherapy-induced Nausea and Vomiting
M.D. Anderson Cancer Center
Merck Sharp & Dohme LLC

Completed

Fosaprepitant in Patients Receiving Ifosfamide-based Regimen

Sarcoma | Chemotherapy-induced Nausea and Vomiting | Effects of Chemotherapy | Adverse Effects of Medical Drugs

United States
Sun Yat-sen University

Completed

Aprepitant Triple Therapy for the Prevention of CINV in Nondrinking and Young Women Who Received Moderately Emetogenic Chemotherapy (CINV)

Gastrointestinal Neoplasms | Chemotherapy-induced Nausea and Vomiting

China
Second Affiliated Hospital, School of Medicine,...

Not yet recruiting

Efficacy and Safety of Intravenous Versus Oral 5-HT3 Antagonists Combined With NK-1 Receptor Antagonists for the Prevention of CINV in Breast Cancer

Breast Cancer | Chemotherapy-induced Nausea and Vomiting

China
Dartmouth-Hitchcock Medical Center

Completed

Community-Led Action Research in Oncology: Improving Symptom Management (CLARO)

Depression | Neoplasms | Fatigue | Chemotherapy-induced Nausea and Vomiting | Anxiety | Chemotherapy-induced Neutropenia

United States, Honduras
Eisai Inc.

Completed

A Study of Palonosetron for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Participants Who Have Experienced CINV(Chemotherapy-Induced Nausea and Vomiting) During the Previous Cycle of Low Emetogenic Chemotherapy (LEC)

Patients With Confirmed Malignant Disease to Receive Low Emetogenic Chemotherapy (LEC) or Who Experienced at Least Nausea and Vomiting During Last Cycle of LEC

United States
Centre Hospitalier Universitaire de la Réunion

Recruiting

Effects of Short-term Therapeutic Fasting on Nausea and Vomiting Due to Chemotherapy (CHEMO-FAST)

Vomiting | Nausea Post Chemotherapy

France
Christina Ruhlmann
Helsinn Healthcare SA

Recruiting

Safety and Antiemetic Efficacy of Akynzeo Plus Dexamethasone During Radiotherapy and Concomitant Weekly Cisplatin

Cervical Cancer | Chemotherapy-induced Nausea and Vomiting | Adverse Event

Denmark
Lawson Health Research Institute

Recruiting

Implementation of Personalized Medicine for Optimal Drug Therapy in Cancer

Cancer Pain | Nausea With Vomiting Chemotherapy-Induced | Depression, Reactive

Canada
M.D. Anderson Cancer Center
Eisai Inc.

Completed

Palonosetron Versus Ondansetron for the Prevention of Nausea and Vomiting

Chemotherapy-induced Nausea and Vomiting | Acute Myelogenous Leukemia

United States
Zunyi Medical College
Guizhou Provincial People's Hospital; Sichuan Cancer Hospital and Research... and other collaborators

Recruiting

Olanzapine for the Prevention and Treatment of Nausea and Vomiting Induced by Chemotherapy of Lung Cancer

Chemotherapy-induced Nausea and Vomiting | Lung Cancer

China
Seoul National University Hospital

Completed

Ramosetron Versus Ondansetron for Radiotherapy Induced Nausea and Vomiting

Radiotherapy Induced Nausea and Vomiting

Korea, Republic of
Zhejiang University
Merck Sharp & Dohme LLC

Unknown

Safety and Efficacy of Aprepitant for CINV in Patients With Lung Cancer Receiving Multiple-day Cisplatin Chemotherapy

Lung Cancer | Chemotherapy-Induced Nausea and Vomiting

China
The Hospital for Sick Children

Terminated

Relative Bioavailability of an Extemporaneous Oral Suspension of Aprepitant in Adolescents

Nausea | Vomiting | Chemotherapy

Canada
National Center for Complementary and Integrative...

Completed

Ginger Control of Chemotherapy Induced Nausea and Vomiting

Nausea | Vomiting | Chemotherapy

United States, Puerto Rico

Clinical Trials on Nausea With Vomiting Chemotherapy-Induced

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Thailand

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations